Transaction · 0001856079-26-000002

Oxford Science Enterprises PLC

Oxford Science Enterprises plc, 10%, reported a transaction classified as unknown at Barinthus Biotherapeutics plc. involving 8797770.000000 shares for an estimated $976552.47. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code U10%
BRNSBarinthus Biotherapeutics plc.
Trade date
Sep 09, 2026
Filing date
Sep 11, 2026
View on SEC Insider profile
Disclosed value-$976kShares × reported price
Shares traded8.79M$0.11 per share
Holdings after0Direct
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
amended filingThis transaction comes from an amended Form 4 filing.

BRNS price since this filing

Daily closing prices, with the filing date and available return windows
BRNS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code U
Identifier
0001856079-26-000002
Ordinary Shares
Transaction date
Sep 09, 2026
Filed Sep 11, 2026, 03:00 PM · 2d delay
Shares
8,797,770 sh
$0.11 per share
Estimated value
-$976k
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Direct Ownership
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% NoOther Yes
Footnotes & amended
  1. F1

    Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.

  2. F2

    Pursuant to the terms of the Merger Agreement between Barinthus Biotherapeutics plc (the "Issuer") and Clywedog Therapeutics, Inc., the Issuer's board of directors has determined that each of the Issu…

Amended filing · 0001856079-26-000002
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BRNS